2024 -2025 Scientific and Technical Advisor, SAB Chair @
2021 -2023 Chief Technology Officer @
2020 -2021 Consulting for gene and cell therapy startups - non-viral vectors and engineered cell products @ Freelance
2019 -2020 VP, Technical Development and Manufacturing @
2016 -2018 VP Technical Development and Manufacturing @ Editas Medicine
2008 -2016 Novartis, Executive Director Cell and Gene Therapies @
2007 -2008 Director Protein Expression and Purification Research @ Shire Human Genetic Therapies
2001 -2006 Sr. Director Molecular Biology and Gene Expression @ Antigenics
1998 -2001 Director Molecular Immunology @ Aquila Biopharmaceuticals
1994 -1998 Principle Investigator II @ Procept Inc., Vactex, Inc.
1991 -1994 Assistant Professor of Medicine @ Beth Israel Hospital and Harvard Medical School
1988 -1991 Cancer Research Institute Postdoc, MIT Cancer Center, Sharp Lab @
Ken Leclair Education
Massachusetts Institute of Technology
Postdoc
1988-1991
Yale University
Ph.D. (Immunobiology)
1981-1987
Bowdoin College
A.B. (Biology)
1973-1977
Ken Leclair Skills
Immunology
Protein Expression
Molecular Biology
Life Sciences
Vaccines
Gene Therapy
Cell Therapy
Genome Analysis
Genome Sequencing
Medicine
Technology
Ken Leclair Summary
Ken Leclair, based in Wellesley, MA, US, is currently a Cell and Gene Therapy Technical Advisor, Board Memberships at Freelance. Ken Leclair brings experience from previous roles at JURA Bio, Inc., RoslinCT and Freelance. Ken Leclair holds a 1988 - 1991 Postdoc @ Massachusetts Institute of Technology. With a robust skill set that includes Immunology, Protein Expression, Molecular Biology, Life Sciences, Vaccines and more. Ken Leclair has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ken Leclair?
Find contact details for 700 million professionals.